Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -15.16%48.1B | -6.98%54.71B | 5.84%74.32B | -5.69%60.92B | -14.32%56.7B | -16.02%58.82B | 2.68%70.22B | 6.60%64.59B | 65.86%66.17B | 51.35%70.04B |
Transactional financial assets | -9.53%2.7B | -3.12%2.53B | -9.44%2.51B | -0.41%2.93B | 2.24%2.98B | -11.75%2.61B | -19.81%2.77B | -9.79%2.94B | -11.07%2.92B | -10.10%2.95B |
Notes receivable and accounts receivable | 27.90%70.81B | 43.81%58.87B | 20.63%63.08B | 24.29%62.11B | 34.72%55.36B | 45.02%40.94B | 35.06%52.29B | 39.45%49.97B | 26.17%41.09B | 42.07%28.23B |
-Notes receivable | 116.87%1.59B | 33.02%1.27B | 44.05%482.86M | 640.92%2.05B | 75.55%734.88M | 267.72%957.04M | -49.50%335.2M | -39.76%276.56M | 82.01%418.61M | -49.88%260.26M |
-Accounts receivable | 26.70%69.21B | 44.06%57.6B | 20.48%62.6B | 20.86%60.06B | 34.30%54.63B | 42.95%39.98B | 36.54%51.96B | 40.48%49.69B | 25.77%40.68B | 44.54%27.97B |
Other receivables (including interest and dividends) | 10.17%4.36B | 19.01%4.44B | -3.79%4.03B | 3.21%4.14B | 2.42%3.96B | -3.83%3.73B | 19.04%4.19B | 17.54%4.01B | 10.98%3.87B | 19.69%3.88B |
-Dividend receivable | ---- | ---- | ---- | -98.37%591.5K | ---- | ---- | ---- | --36.29M | ---- | ---- |
-Other receivable | ---- | ---- | ---- | 4.14%4.14B | ---- | -3.83%3.73B | ---- | 16.48%3.98B | ---- | 19.69%3.88B |
Contractual assets | 29.60%376.69M | -6.35%282.78M | -6.59%294.97M | -0.47%323.61M | -9.29%290.66M | -7.22%301.94M | -22.69%315.79M | -12.30%325.15M | -27.67%320.41M | -30.36%325.45M |
Advance payment | 16.71%7.47B | 10.15%6.46B | -12.71%6.75B | -12.90%5.84B | -17.57%6.4B | -25.18%5.87B | -11.34%7.73B | -19.48%6.71B | -11.28%7.77B | 4.42%7.84B |
Inventories | 3.19%3.24B | 11.08%2.46B | 26.44%4.22B | 9.39%4.2B | -1.79%3.14B | 17.79%2.22B | -11.49%3.34B | 15.26%3.84B | -12.01%3.19B | 1.94%1.88B |
Non-current assets due within one year | 18.12%2.9B | 49.06%2.96B | 9.65%2.69B | -39.16%2.42B | -34.56%2.45B | -5.00%1.98B | 103.35%2.46B | 206.20%3.97B | 361.57%3.75B | 177.74%2.09B |
Other current assets | -38.65%21.12B | -37.24%26.09B | -26.23%21.75B | -5.31%30.97B | 14.95%34.43B | 43.18%41.56B | 9.25%29.48B | 13.48%32.7B | -18.94%29.95B | -32.49%29.03B |
Total current assets | -2.80%161.08B | 0.49%158.81B | 3.97%179.65B | 2.83%173.85B | 4.20%165.71B | 8.04%158.03B | 11.36%172.79B | 16.39%169.06B | 22.50%159.03B | 15.85%146.27B |
Non Current assets | ||||||||||
Debt investment | 3,580.58%15.72B | 3,513.03%15.63B | -1.49%424.78M | --435.64M | --427.03M | --432.53M | --431.2M | ---- | ---- | ---- |
Other debt investment | -19.03%1.37B | -35.20%1.31B | -30.74%1.2B | -5.92%1.41B | 29.01%1.69B | 78.26%2.02B | 100.17%1.74B | 54.17%1.5B | 48.25%1.31B | 24.86%1.13B |
Other equity investment | 8.30%2.48B | 8.24%2.21B | 16.69%2.5B | 4.73%2.24B | 6.23%2.29B | 10.54%2.04B | 22.54%2.14B | -12.03%2.13B | -3.44%2.16B | -7.89%1.85B |
Other non-current financial assets | -0.63%1.15B | -0.75%1.15B | -5.62%1.1B | 0.58%1.14B | 2.40%1.15B | 2.45%1.16B | 41.40%1.17B | 41.35%1.14B | 36.49%1.13B | 40.75%1.13B |
Long-term equity investment | 3.60%57.52B | 3.83%56.51B | 6.15%55.91B | 7.18%55.26B | 6.93%55.52B | 6.61%54.43B | 4.87%52.67B | 4.73%51.56B | 5.26%51.92B | 5.44%51.05B |
Long term receivable account | -20.74%782.9M | 4.45%889.45M | -38.96%753.09M | -28.82%894.43M | 60.41%987.73M | 38.43%851.57M | -46.40%1.23B | -45.22%1.26B | -71.68%615.76M | -56.08%615.18M |
Fixed assets | ---- | ---- | ---- | 1.89%298.92B | ---- | 0.54%304.91B | ---- | -0.85%293.39B | ---- | -2.45%303.28B |
Fixed assets liquidation | ---- | ---- | ---- | -97.53%1.84M | ---- | --2.37M | ---- | 193.24%74.52M | ---- | ---- |
Constru in process | ---- | ---- | ---- | -6.06%44.58B | ---- | 4.29%46.42B | ---- | 2.68%47.46B | ---- | 8.94%44.51B |
Construction materials | ---- | ---- | ---- | -66.93%499.35M | ---- | -39.18%731.64M | ---- | -26.96%1.51B | ---- | 260.36%1.2B |
Intangible assets | -1.14%29.8B | -1.04%30.91B | -5.72%28.03B | 1.28%29.73B | 3.68%30.15B | 4.64%31.23B | 7.84%29.73B | 8.46%29.36B | 7.90%29.08B | 9.84%29.85B |
Development expenditure | -9.52%3.16B | -8.77%2.84B | 2.71%3.41B | 15.88%3.79B | 7.78%3.49B | 12.99%3.11B | 29.14%3.32B | 30.72%3.27B | 35.14%3.24B | 32.98%2.75B |
Long deferred expense | 27.85%3.75B | -2.83%2.85B | -32.84%2.61B | -17.39%2.71B | -20.71%2.93B | -10.43%2.93B | 1.34%3.88B | 3.52%3.28B | 11.52%3.7B | 7.40%3.28B |
Deferred tax assets | 74.31%1.53B | 53.74%1.26B | 105.14%1.66B | 172.07%1.57B | 66.66%877.27M | 74.12%816.68M | 51.30%807.19M | 49.73%576.8M | 71.14%526.36M | 72.87%469.03M |
Usufruct assets | -17.76%35.74B | -13.80%38.04B | -11.93%40.18B | -10.59%41.62B | -11.11%43.45B | -12.66%44.14B | 129.29%45.62B | 116.62%46.55B | 112.23%48.88B | 111.16%50.53B |
Other non current assets | -11.00%8.42B | 2.46%9.83B | 23.74%9.73B | 18.58%9.69B | 40.59%9.45B | 41.73%9.59B | 41.03%7.86B | 45.38%8.17B | 42.03%6.73B | 38.26%6.77B |
Total non current assets | 1.29%506.57B | 1.82%514.03B | -0.24%491.89B | 0.66%494.49B | 1.51%500.14B | 1.28%504.82B | 6.78%493.05B | 6.74%491.23B | 7.22%492.71B | 6.72%498.42B |
Total assets | 0.27%667.65B | 1.51%672.84B | 0.85%671.53B | 1.22%668.34B | 2.17%665.86B | 2.82%662.84B | 7.93%665.85B | 9.06%660.29B | 10.58%651.74B | 8.66%644.69B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | 33.94%710.62M | 4.41%710.65M | -19.79%690.58M | -3.10%690.66M | -6.92%530.54M | 35.55%680.63M | 88.30%860.92M | 54.12%712.78M | 22.72%569.97M | 30.33%502.11M |
Notes payable and accounts payable | 1.02%172.43B | 4.72%175.52B | 4.23%172.04B | 7.55%169.77B | 10.27%170.7B | 12.24%167.61B | 9.89%165.06B | 12.41%157.85B | 16.96%154.8B | 15.09%149.34B |
-Notes payable | -5.79%15.59B | -0.84%15.48B | 19.10%15.47B | 42.77%14.93B | 43.74%16.54B | 53.47%15.62B | 6.72%12.99B | -7.06%10.46B | 34.68%11.51B | 60.92%10.18B |
-Accounts payable | 1.75%156.85B | 5.29%160.04B | 2.96%156.57B | 5.06%154.84B | 7.58%154.16B | 9.22%152B | 10.16%152.07B | 14.11%147.39B | 15.74%143.29B | 12.74%139.16B |
Contract liabilities | 0.50%41.93B | 1.20%46.76B | -2.69%40.89B | -4.56%40.33B | -2.44%41.72B | 3.31%46.21B | 2.35%42.03B | 2.23%42.25B | 3.71%42.77B | -2.15%44.73B |
Advance receipts | -10.54%211.09M | -22.34%226.09M | 1.98%228.44M | 4.55%250.97M | -23.89%235.97M | -26.03%291.12M | -40.45%224M | -30.70%240.05M | 157.80%310.03M | 222.63%393.57M |
Salaries payable | -18.83%8.62B | -24.37%8.63B | -43.43%9.81B | -36.41%11.08B | -24.52%10.62B | -23.28%11.41B | -16.93%17.34B | -10.71%17.43B | -16.57%14.06B | -5.35%14.87B |
Taxs payable | -0.18%5.02B | -23.54%2.72B | -6.85%4.09B | 21.68%4.51B | 18.29%5.02B | 59.69%3.55B | 73.86%4.39B | 41.08%3.71B | 94.83%4.25B | 54.64%2.22B |
Other payable (including interest and dividends) | -2.75%14.68B | -1.38%14.94B | 8.83%20.12B | 10.32%18.35B | -5.72%15.09B | -3.64%15.15B | 29.98%18.48B | 29.58%16.64B | 4.31%16.01B | -0.85%15.72B |
-Dividend payable | ---- | ---- | ---- | 22.77%3.12B | ---- | 173.25%6.19M | ---- | 111,944.03%2.54B | ---- | 0.00%2.27M |
-Other payable | ---- | ---- | ---- | 8.08%15.24B | ---- | -3.66%15.14B | ---- | 9.82%14.1B | ---- | -0.85%15.72B |
Non current liabilities due within one year | 1.83%13.7B | 8.86%14.15B | 13.39%13.43B | 11.88%13.45B | 4.93%13.46B | 1.03%13B | 28.94%11.84B | 10.03%12.02B | -9.76%12.82B | -17.34%12.86B |
Other current liabilities | -9.41%1.82B | -2.42%2.32B | -3.27%1.89B | -73.45%1.9B | -71.10%2.01B | -67.56%2.38B | -75.31%1.96B | -22.53%7.16B | 106.30%6.97B | -30.69%7.34B |
Total current liabilities | -0.10%259.12B | 2.19%265.98B | 0.38%263.18B | 0.90%260.34B | 2.71%259.39B | 4.96%260.29B | 6.22%262.18B | 8.54%258.01B | 11.68%252.56B | 5.46%247.98B |
Current liabilities | ||||||||||
Long term loan | 5.51%2.26B | -0.26%2.13B | 22.88%1.98B | 20.31%2B | 20.38%2.14B | 16.72%2.13B | 0.20%1.61B | -0.71%1.66B | 0.53%1.78B | -0.40%1.83B |
Long term salaries pay | 20.04%138.12M | 20.12%136.66M | 11.37%118.11M | 9.85%116.49M | 10.04%115.07M | 8.79%113.77M | 6.05%106.05M | 8.81%106.05M | 9.92%104.57M | 8.96%104.57M |
Estimate liabilities | 24.56%267.53M | 32.54%279.94M | -7.98%201.71M | -21.44%202.81M | -15.49%214.78M | -13.57%211.22M | 32.26%219.21M | 79.13%258.18M | 96.47%254.15M | 98.92%244.37M |
Deferred tax liabilities | -66.54%191.36M | 38.20%2.38B | 43.39%760.44M | -53.32%169.22M | -17.73%571.89M | -18.79%1.72B | -67.75%530.33M | -65.01%362.52M | -47.96%695.16M | 29.55%2.12B |
Long term deferred income | -12.88%8.06B | -10.68%8.23B | -0.11%8.62B | 5.51%8.72B | 13.46%9.26B | 17.62%9.21B | 13.90%8.63B | 11.31%8.26B | 15.59%8.16B | 12.68%7.83B |
Lease liabilities | -24.86%22.27B | -20.89%24.22B | -19.48%26.65B | -16.77%27.94B | -14.77%29.64B | -15.96%30.62B | 203.21%33.1B | 211.17%33.57B | 217.88%34.78B | 249.78%36.43B |
Other non current liabilities | 13.25%700M | 13.28%692.43M | 10.61%632.13M | 10.60%624.92M | -6.22%618.09M | -29.12%611.27M | -33.67%571.5M | -35.33%565.03M | -24.01%659.11M | -0.57%862.42M |
Total non current liabilities | -20.36%33.9B | -14.69%38.07B | -12.96%38.97B | -11.20%39.78B | -8.36%42.56B | -9.72%44.62B | 95.51%44.78B | 103.15%44.8B | 108.90%46.44B | 125.33%49.43B |
Total liabilities | -2.96%293.02B | -0.28%304.05B | -1.56%302.16B | -0.89%300.12B | 0.99%301.95B | 2.52%304.91B | 13.80%306.96B | 16.57%302.8B | 20.38%299B | 15.69%297.41B |
Shareholders equity | ||||||||||
Paid-in capital | -1.69%31.26B | -0.01%31.8B | -0.01%31.8B | -0.01%31.8B | -0.01%31.8B | -0.00%31.8B | 2.71%31.8B | 2.63%31.8B | 2.63%31.8B | 2.62%31.8B |
Capital reserve funds | -1.77%80.83B | 0.38%82.51B | 0.46%82.43B | 0.48%82.37B | 0.48%82.29B | 0.46%82.2B | 2.04%82.05B | 1.90%81.98B | 1.78%81.9B | 1.72%81.82B |
Surplus reserve funds | 17.41%3.5B | 17.41%3.5B | 16.69%2.98B | 16.69%2.98B | 16.69%2.98B | 16.69%2.98B | 16.16%2.55B | 16.16%2.55B | 16.16%2.55B | 16.16%2.55B |
Retained profit | 7.79%55.78B | 7.85%53.17B | 8.48%56B | 8.51%53.7B | 8.61%51.75B | 8.64%49.3B | 9.17%51.62B | 9.39%49.49B | 9.09%47.64B | 8.97%45.38B |
Less:Treasury stock | -71.14%1.23B | -18.40%3.5B | -0.20%4.28B | -0.24%4.28B | -0.52%4.28B | -0.32%4.28B | 93.08%4.28B | 86.15%4.29B | 39.99%4.3B | 39.42%4.3B |
Other composite income | -1.50%-3.19B | 3.53%-3.15B | 3.34%-3.09B | 0.50%-3.17B | 5.05%-3.15B | 4.04%-3.26B | 5.83%-3.2B | 1.22%-3.18B | 2.93%-3.31B | 2.45%-3.4B |
Ordinary risk reserve funds | 0.00%507.5M | 0.00%507.5M | 0.00%507.5M | 0.00%507.5M | 0.00%507.5M | 0.00%507.5M | 0.00%507.5M | 0.00%507.5M | 0.00%507.5M | 0.00%507.5M |
Specific reserves | 31.90%1.13M | 28.47%677.92K | --1.27M | --1.2M | --855.17K | --527.68K | ---- | ---- | ---- | ---- |
Shareholders equity without minority interests | 3.43%167.45B | 3.52%164.85B | 3.29%166.35B | 3.18%163.92B | 3.25%161.9B | 3.15%159.24B | 3.40%161.05B | 3.25%158.87B | 3.60%156.79B | 3.45%154.37B |
Minority interests | 2.56%207.18B | 2.64%203.94B | 2.62%203.03B | 2.86%204.3B | 3.09%202B | 3.00%198.69B | 3.36%197.84B | 3.55%198.62B | 3.32%195.94B | 3.16%192.9B |
Total shareholder equity | 2.95%374.63B | 3.03%368.79B | 2.92%369.38B | 3.00%368.22B | 3.17%363.9B | 3.07%357.94B | 3.38%358.89B | 3.42%357.49B | 3.44%352.74B | 3.29%347.27B |
Total liabilityies and equity | 0.27%667.65B | 1.51%672.84B | 0.85%671.53B | 1.22%668.34B | 2.17%665.86B | 2.82%662.84B | 7.93%665.85B | 9.06%660.29B | 10.58%651.74B | 8.66%644.69B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.